Effectiveness of a Novel Neural Tissue Management to Improve Short-term Pain and Disability in Patients With Sciatica
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03663842|
Recruitment Status : Completed
First Posted : September 10, 2018
Last Update Posted : September 10, 2018
|Condition or disease||Intervention/treatment||Phase|
|Sciatica Pain Physical Therapy Modalities Manual Therapies Disability Evaluation||Other: Physical therapy treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||44 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effectiveness of a Novel Neural Tissue Management to Improve Short-term Pain and Disability in Patients With Sciatica|
|Actual Study Start Date :||May 10, 2010|
|Actual Primary Completion Date :||November 10, 2010|
|Actual Study Completion Date :||December 10, 2010|
Experimental: Neural tissue management
Myofascial release technique; Hip joint mobilization technique; Cross-fiber friction over the sacroiliac joints; Neural mobilization to improve sciatic nerve excursion.
Other: Physical therapy treatment
All patients underwent the same techniques, and there was no modification of the intervention protocol during the study: (1) Myofascial release technique - piriformis muscle and biceps femoral muscle; (2) Hip joint mobilization; (3) Cross-fiber friction over the sacroiliac joints; (4) Neural mobilization to improve sciatic nerve excursion.
- Pain intensity [ Time Frame: From enrollment to end of treatment at 12 weeks ]Measured by the Numerical Rating Scale (NRS 0-10)
- Lumbar disability [ Time Frame: From enrollment to end of treatment at 12 weeks. ]Assessed by the Oswestry Disability Index (ODI).It consists of 10 items addressing different aspects of disability. Each item is scored from 0 to 5, with higher values representing greater disability. The sum of the item scores is divided by the total possible score (50 if all sections are completed), and the resulting total is multiplied by 100 to be described as a percentage score.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03663842
|Principal Investigator:||Renato Almeida, PhD||Centro Universitário Augusto Motta|